Max Delbrück Center

ExpertiseUpdated on 2 December 2025

R&D Leader and Function Builder

R&D Leader

Berlin, Germany

About

Working at the intersection of R&D and strategy, I build high-performing teams and drive collaboration across disciplines to turn scientific ideas into successful biotech products.

I build and guide effective, efficient and engaged R&D departments by shaping the science — defining what an application needs to be, driving the development work — by building the teams around it, and by creating the structure and processes that keep everything aligned and moving forward.

Field

  • DISEASE AREA | Metabolic Diseases
  • MEDICINE | Cell Therapy
  • TECHNOLOGY | Other

Similar opportunities

  • Expertise

    Tailored Biomarker Solutions for your Clinical Programs

    • DISEASE AREA | Cancer
    • MEDICINE | Diagnostics
    • MEDICINE | Cell Therapy
    • MEDICINE | Early Detection
    • MEDICINE | RNA-based Therapy
    • MEDICINE | Therapy Monitoring
    • MEDICINE | Biomarker Discovery
    • DISEASE AREA | Metabolic Diseases
    • DISEASE AREA | Infectious Diseases
    • TECHNOLOGY | (Single-cell) multi-omics
    • DISEASE AREA | Inflammation / Autoimmune Diseases

    Andreas Hüser

    CEO at CheckImmune GmbH

    Berlin, Germany

  • Expertise

    New Approach Methodologies (NAM) Training Program

    • TECHNOLOGY | Other
    • DISEASE AREA | Cancer
    • DISEASE AREA | Other
    • MEDICINE | Gene Therapy
    • MEDICINE | Cell Therapy
    • MEDICINE | Drug Screening
    • TECHNOLOGY | Bioengineering
    • MEDICINE | RNA-based Therapy
    • MEDICINE | Drug Target Discovery
    • DISEASE AREA | Metabolic Diseases
    • DISEASE AREA | Infectious Diseases
    • TECHNOLOGY | Personalized disease models
    • DISEASE AREA | Inflammation / Autoimmune Diseases

    Marty Steiger

    Application Scientist at Dynamic42 GmbH

    Germany

  • Partnership

    HPC-Gateway: Fast-Track Access to Helmholtz High-Performance Computing Power

    • Research
    • Joint development
    • Knowledge transfer
    • Technology transfer

    Egemen Agi

    Innovation and Entrepreneurship Manager at Max Delbrück Center for Molecular Medicine

    Berlin, Germany